Claire Fraser Becton Dickinson & CO (BDX) insider trading activity

Claire Fraser is Director of BECTON DICKINSON & CO. Currently has a direct ownership of 24,006 shares of BDX, which is worth approximately $5.94 Million. The most recent transaction as insider was on Jan 28, 2025, when has been sold 930 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24K

5.77% 3M change

5.77% 12M change

Total Value Held $5.94 Million

Claire Fraser Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 28 2025	BUY Grant, award, or other acquisition	-	930 Added 3.73%	24,006 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	900 Added 3.81%	22,696 Common Stock
Aug 28 2023	SELL Open market or private sale	$238,847 $281.66 p/Share	848 Reduced 3.78%	21,608 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	848 Added 3.66%	22,311 Common Stock
Feb 08 2022	SELL Open market or private sale	$228,500 $271.7 p/Share	841 Reduced 3.75%	21,556 Common Stock
Jan 25 2022	BUY Grant, award, or other acquisition	-	820 Added 3.53%	22,397 Common Stock
Aug 18 2021	SELL Open market or private sale	$97,361 $251.58 p/Share	387 Reduced 1.88%	20,220 Common Stock
May 27 2021	SELL Open market or private sale	$94,130 $241.36 p/Share	390 Reduced 1.86%	20,607 Common Stock
Jan 26 2021	BUY Grant, award, or other acquisition	-	829 Added 3.8%	20,997 Common Stock

Also insider at

MCRB

Seres Therapeutics, Inc. Healthcare

Claire Fraser

Director

Franklin Lakes, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDX shares.

Notify only if

Value

Insider Trading

Get notified when an Becton Dickinson & CO insider buys or sells BDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BECTON DICKINSON & CO

Track Activities on BDX

Account